Cargando…
Pedigree investigation, clinical characteristics, and prognosis analysis of haematological disease patients with germline TET2 mutation
BACKGROUND: Increasing germline gene mutations have been discovered in haematological malignancies with the development of next-generation sequencing (NGS), which is critical for proper clinical management and long-term follow-up of affected individuals. Tet methylcytosine dioxygenase 2 (TET2) is on...
Autores principales: | Wu, Xia, Deng, Jili, Zhang, Nanchen, Liu, Xiaoyan, Zheng, Xue, Yan, Tianyou, Ye, Wu, Gong, Yuping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8917718/ https://www.ncbi.nlm.nih.gov/pubmed/35279121 http://dx.doi.org/10.1186/s12885-022-09347-0 |
Ejemplares similares
-
Clinical characteristics and registry-validated extended pedigrees of germline TP53 mutation carriers in Denmark
por: Stoltze, Ulrik, et al.
Publicado: (2018) -
The m(6)A RNA methyltransferase METTL3/METTL14 promotes leukemogenesis through the mdm2/p53 pathway in acute myeloid leukemia
por: Sang, Lina, et al.
Publicado: (2022) -
Vitamin C boosts DNA demethylation in TET2 germline mutation carriers
por: Taira, Aurora, et al.
Publicado: (2023) -
Comparison of monoclonal antibodies targeting CD38, SLAMF7 and PD-1/PD-L1 in combination with Bortezomib/Immunomodulators plus dexamethasone/prednisone for the treatment of multiple myeloma: an indirect-comparison Meta-analysis of randomised controlled trials
por: Ye, Wu, et al.
Publicado: (2021) -
The Mutationathon highlights the importance of reaching standardization in estimates of pedigree-based germline mutation rates
por: Bergeron, Lucie A, et al.
Publicado: (2022)